60 likes | 80 Views
Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.<br><br>
E N D
Veterinary Dermatology Drugs Market CAGR (2023 – 2030) 7.67% Market Size (2022) US$ 2.43 MN
Segmentation (Scope) By Animal Type By Type of Drug By End User • Dogs • Antibiotics • Animal Hospitals • Antifungal drugs • Cats • Horses • Others • Animal Ambulatory Surgical • Anti-inflammatory drugs • Others • Others © Coherent Market Insights. All Rights Reserved
Major Drivers • Increasing incidence of skin diseases in animals • Growing adoption of pets • Advancements in veterinary medicine • Demand for novel drugs for animal skin diseases © Coherent Market Insights. All Rights Reserved
NORTH AMERICA ASIA PACIFIC Major Drivers Major Drivers • Increasing number of approved products • Increasing demand for technologically advanced products • Presence of leading companies in the region • Increasing prevalence of respiratory disorders © Coherent Market Insights. All Rights Reserved
Medtronic Plc • Zoetis Inc., • ElancoAnimal Health Incorporated, • BoehringerIngelheim International GmbH, • Virbac, Vetoquinol S.A., • DechraPharmaceuticals PLC, • Bayer AG, CevaSanteAnimale, • Kindred Biosciences, Inc., IDEXX • Laboratories, Inc. Major Players © Coherent Market Insights. All Rights Reserved